Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy

被引:87
作者
Badrinath, Narayanasamy [1 ,2 ]
Yoo, So Young [2 ,3 ]
机构
[1] Pusan Natl Univ, Sch Med, Biomed Sci, Yangsan 50612, South Korea
[2] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan 50612, South Korea
[3] Pusan Natl Univ, BIO IT Foundry Technol Inst, Busan 46241, South Korea
基金
新加坡国家研究基金会;
关键词
CELL-DEATH PATHWAY; DNA MUTATIONS; COMPLEX-I; MICROSATELLITE INSTABILITY; COLORECTAL CARCINOMAS; HEXOKINASE-II; CYTOCHROME-C; GENOMIC INSTABILITY; AEROBIC GLYCOLYSIS; PYLORI INFECTION;
D O I
10.1093/carcin/bgy148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mitochondria play pivotal roles in most eukaryotic cells, ranging from energy production to regulation of apoptosis. As sites of cellular respiration, mitochondria experience accumulation of reactive oxygen species (ROS) due to damage in electron transport chain carriers. Mutations in mitochondrial DNA (mtDNA) as well as nuclear DNA are reported in various cancers. Mitochondria have a dual role in cancer: the development of tumors due to mutations in mitochondrial genome and the generation of ROS. Impairment in the mitochondria-regulated apoptosis pathway accelerates tumorigenesis. Numerous strategies targeting mitochondria have been developed to induce the mitochondrial (i.e. intrinsic) apoptosis pathway in cancer cells. This review elaborates the roles of mitochondria in cancer with respect to mutations and apoptosis and discusses mitochondria-targeting strategies as cancer therapies to enhance the killing of cancer cells.
引用
收藏
页码:1419 / 1430
页数:12
相关论文
共 139 条
[1]   Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling [J].
Adam, Julie ;
Hatipoglu, Emine ;
O'Flaherty, Linda ;
Ternette, Nicola ;
Sahgal, Natasha ;
Lockstone, Helen ;
Baban, Dilair ;
Nye, Emma ;
Stamp, Gordon W. ;
Wolhuter, Kathryn ;
Stevens, Marcus ;
Fischer, Roman ;
Carmeliet, Peter ;
Maxwell, Patrick H. ;
Pugh, Chris W. ;
Frizzell, Norma ;
Soga, Tomoyoshi ;
Kessler, Benedikt M. ;
El-Bahrawy, Mona ;
Ratcliffe, Peter J. ;
Pollard, Patrick J. .
CANCER CELL, 2011, 20 (04) :524-537
[2]  
Amundson SA, 2000, CANCER RES, V60, P6101
[3]   SEQUENCE AND ORGANIZATION OF THE HUMAN MITOCHONDRIAL GENOME [J].
ANDERSON, S ;
BANKIER, AT ;
BARRELL, BG ;
DEBRUIJN, MHL ;
COULSON, AR ;
DROUIN, J ;
EPERON, IC ;
NIERLICH, DP ;
ROE, BA ;
SANGER, F ;
SCHREIER, PH ;
SMITH, AJH ;
STADEN, R ;
YOUNG, IG .
NATURE, 1981, 290 (5806) :457-465
[4]   Electron microscopy morphology of the mitochondrial network in gliomas and their vascular microenvironment [J].
Arismendi-Morillo, Gabriel .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2011, 1807 (06) :602-608
[5]   Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment [J].
Arnold, Rebecca S. ;
Fedewa, Stacey A. ;
Goodman, Michael ;
Osunkoya, Adeboye O. ;
Kissick, Haydn T. ;
Morrissey, Colm ;
True, Lawrence D. ;
Petros, John A. .
BONE, 2015, 78 :81-86
[6]   Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma [J].
Astuti, D ;
Latif, F ;
Dallol, A ;
Dahia, PLM ;
Douglas, F ;
George, E ;
Sköldberg, F ;
Husebye, ES ;
Eng, C ;
Maher, ER .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (01) :49-54
[7]   Viruses as nanomedicine for cancer [J].
Badrinath, Narayanasamy ;
Heo, Jeong ;
Yoo, So Young .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 :4835-4847
[8]   Targeting Apoptosis Pathways for New Cancer Therapeutics [J].
Bai, Longchuan ;
Wang, Shaomeng .
ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 :139-155
[9]   SDH mutations in cancer [J].
Bardella, Chiara ;
Pollard, Patrick J. ;
Tomlinson, Ian .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2011, 1807 (11) :1432-1443
[10]   ATP citrate lyase is an important component of cell growth and transformation [J].
Bauer, DE ;
Hatzivassiliou, G ;
Zhao, FP ;
Andreadis, C ;
Thompson, CB .
ONCOGENE, 2005, 24 (41) :6314-6322